University of Wollongong

Research Online
Faculty of Health and Behavioural Sciences Papers (Archive)

Faculty of Science, Medicine and Health

7-2009

Regulatory issues and functional health claims for bioactive dairy
compounds
P. Roupas
CSIRO

P. G. Williams
University of Wollongong, peterw@uow.edu.au

C. Margetts
CSIRO

Follow this and additional works at: https://ro.uow.edu.au/hbspapers
Part of the Arts and Humanities Commons, Life Sciences Commons, Medicine and Health Sciences
Commons, and the Social and Behavioral Sciences Commons

Recommended Citation
Roupas, P.; Williams, P. G.; and Margetts, C.: Regulatory issues and functional health claims for bioactive
dairy compounds 2009.
https://ro.uow.edu.au/hbspapers/111

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Regulatory issues and functional health claims for bioactive dairy compounds
Abstract
Dairy foods and ingredients have a natural advantage over new/novel foods, from a regulatory viewpoint,
because they are generally considered as “traditional” foods, that is, there is a long history of human
consumption. However, the regulatory landscape on adding bioactive ingredients, whether from dairy
streams or from non-dairy sources, into dairy foods is rapidly evolving, and the dairy industry will need to
be aware of potential regulatory challenges, within the countries they wish to market their products.

Keywords
Dairy, functional foods, regulation

Disciplines
Arts and Humanities | Life Sciences | Medicine and Health Sciences | Social and Behavioral Sciences

Publication Details
This book chapter was originally published as Roupas, P, Williams, P and Margetts, C, Regulatory issues
and functional health claims for bioactive dairy compounds, in Park, YW (ed), Bioactive Components in
Milk and Dairy Products, Ames, Wiley-Blackwell, 2009. The definitive version is available here.

This book chapter is available at Research Online: https://ro.uow.edu.au/hbspapers/111

Regulatory Issues and Functional Health Claims for Bioactive Dairy
Compounds

Peter Roupas1, Peter Williams2 and Christine Margetts1

1

CSIRO Food Futures Flagship, and Food Science Australia, 671 Sneydes Road, Werribee,
Victoria 3030, AUSTRALIA.
2

Smart Foods Centre, University of Wollongong, New South Wales 2522, AUSTRALIA.

Corresponding author:
Dr Peter Roupas, Tel: +61 3 9731 3283, Fax: +61 3 9731 3201 e-mail: peter.roupas@csiro.au

Introduction

As research into the health benefits of food components has expanded, both food manufacturers
and consumers have developed a greater understanding of the relationship between food and
health. Bioactive or health promoting components may be naturally present in the food product
or extracted from waste or food streams, for addition to foods not naturally containing them.
Addition of such components may also be used for fortification of foods which naturally contain
these components to compensate for losses that may occur during processing. The development
of the functional food category or foods with health properties beyond the commonly accepted
nutritional benefits is rapidly evolving in all markets.

Milk and its products have long been regarded as a good source of nutrition. Dairy products and
dairy ingredients are also widely used in many other manufactured foods. Current research
undertaken into milk composition reveals it is a significant source of bioactives. Traditional dairy
products such milk beverages and yoghurt are also becoming widely used as vehicles to deliver
non-dairy bioactives, such as phytosterols or omega-3 fatty acids.

This increased ability to enhance the health benefits of food products challenges traditional
views and laws on fortification. The desire for food manufacturers and marketers to utilise new
knowledge on the health-giving qualities of their products to garner market advantage, by
making explicit health claims challenges what is currently permitted by food regulatory codes.

Food regulations vary from country to country and the increased movement of food across
borders and even within large jurisdictions like the European Community, means that a particular
food, ingredient or bioactive may have to meet several sets of regulations, in spite of attempts to
create a global code with Codex Alimentarius.

All new foods require authorisation by relevant regulators but the process each must go through
depends on whether the ingredient or food has a traditional history of consumption in that
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jurisdiction. Non traditional foods (those that do not have a long history of human consumption)
or new foods may be subjected to additional and separate “novel” food regulatory processes.

Regulatory authorities are debating how to deal with health claims, particularly in marketing and
labelling of foods. The levels and types of substantiation required for health claims to be made
for foods and bioactive ingredients are also evolving. This chapter will provide an overview of
the current major approaches taken by larger jurisdictional groups such as the USA, European
Union and Japan to regulating health claims.

Dairy Foods

Clinical, observational and mechanistic data have demonstrated that dairy products and several
of their constituents have a variety of metabolic roles (Smilowitz et al, 2005). Furthermore,
market trends indicate that milk-based beverages and other dairy products such as yoghurt and
cheese are ideal vehicles for newly discovered bioactive food ingredients targeting lifestyle
diseases.

Oral administration of probiotics has been reported to be effective in preventing/treating
diarrhoea, reducing lactose intolerance and allergic diseases, treating irritable bowel syndrome
and reducing blood cholesterol levels (Desmond et al, 2005; Salminen et al, 2005). The
physiological effects of probiotics can occur through either the direct effect of the live microbial
cells, known as the probiotic effect, or indirectly via the metabolites produced by these cells
which is referred to as the biogenic effect. Cheese has also been shown to be an excellent
delivery vehicle for probiotics and biogenic substances (Hayes et al. 2006) and for a variety of
naturally-occurring health-promoting components such as conjugated linoleic acid (CLA) and
omega-3 fatty acids (McIntosh et al. 2006). Probiotics comprise approximately 65% of the
world functional food market.

As there had been no international consensus on methods to assess the efficacy and safety of
probiotic bacteria, recent initiatives from the Food and Agriculture Organization of the United
Nations (FAO), and the World Health Organization (WHO) have resulted in the development of
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a legislative framework for probiotic bacteria which is based on scientific criteria (in vitro trials,
safety considerations, in vivo studies for the substantiation of effects) for the evaluation of health
claims (Pineiro and Stanton, 2007).

Drinking yogurt and low-fat milk and are the most commonly used vehicles for the delivery of
bioactive food ingredients. Probiotic yogurt drinks are preferred for the delivery of plant sterols,
while low-fat milk is commonly used to deliver omega-3 fatty acids. Drinks containing
combinations of dairy and fruit juices, with added bioactive components, are also becoming
common in the USA and European Union (EU) markets (Sharma, 2005).

In addition to being a major provider of important nutrients for humans, including calcium,
protein and riboflavin, it is now recognised that ingredients derived from milk and whey can
provide functional food products with other beneficial effects on human health. Casein and whey
proteins and their derivatives have been shown to possess biological activities, including
peptides able to exert anti-hypertensive (Pihlanto-Leppala, 2000; Lopez-Fandino, et al, 2006)
and other biological effects, lactoferrin and lactoperoxidase able to exert anti-microbial effects,
and growth factors used in sports health and for tissue repair applications including wound repair
(Playne et al, 2003). The currently identified bioactive components in bovine milk or colostrum,
their physiological activities and their concentration in bovine milk have recently been reviewed
(Rowan et al, 2005; Huth et al, 2006).

Dairy foods with added dairy-derived or non-dairy functional ingredients, or non-dairy foods
with added dairy ingredients may be considered by regulatory authorities to be “novel” or “nontraditional” foods i.e. foods that do not have a significant history of human consumption in that
market. Such foods may raise human safety concerns and will need to undergo a risk-based
assessment before being allowed into the food supply (Healy, 2003).

An issue of concern to the dairy industry relates to recent regulations on the labelling of foods
with respect to their levels of trans fatty acids (TFA). With the scientific evidence associating
trans fatty acid intake with an increased risk of coronary heart disease (CHD), the USA Food and
Drug Administration (FDA) has issued a ruling that requires the declaration of the amount of
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TFA present in foods, including dietary supplements, on the nutrition label. For the purpose of
nutrition labelling, TFAs are defined as the sum of all unsaturated fatty acids that contain one or
more isolated (i.e. non-conjugated) double bonds in a trans configuration. The FDA will also be
conducting consumer research to determine consumer understanding of various TFA labelling
possibilities (Moss, 2006). Denmark and New York City have imposed mandatory restrictions on
these types of fats. The recent results from the TRANSFACT study (Chadigny et al, 2008) have
shown differences (in women) between natural ruminant-derived trans fats and industriallyproduced hydrogenated trans fats with respect to biomarkers of CHD. The different effects of
natural, ruminant-derived trans fats and industrially produced trans fats on biomarkers / risk
factors for CHD may result in further regulatory changes as new scientific knowledge is
generated.

Health Claims

Linking the consumption of functional foods or food ingredients with health claims should be
based on sound scientific evidence, with the "gold standard" being replicated, randomized,
placebo-controlled, intervention trials in human subjects. The assessment of scientific safety and
efficacy of a food or ingredient by the relevant regulatory authority is likely to require data on
the characterization and source of the ingredient, manufacturing processes, concentration in the
food product, and related safety considerations. The evidence for confirmation of efficacy may
include in-vitro data, in-vivo animal trials using levels of defined biomarkers as measures of a
physiological effect, but more than one human intervention trial in different population groups is
also likely to be essential. Evaluations will probably include a number of quality criteria such as
the quality of the study design, conduct and analysis and decisions will need to be based on the
totality of the evidence. Not all foods on the market that are claimed to be functional foods are
supported by enough solid data to merit such claims (Hasler, 2002).

Legislation concerning health claims has progressed at a slow pace in many countries. After
several years of debate, the European regulations on nutrition and health claims came into force
in early 2007. This law sets out the conditions on the use of health claims, establishes a system
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for scientific substantiation and should result in an European list of permitted claims by early
2010 (Richardson et al, 2007). Under these regulations, health claims fall into two categories:
structure-function claims (e.g. calcium builds strong bones), and disease risk reduction claims
(e.g. decrease in the risk of heart disease). The latter category will be required to have
substantiated scientific evidence and must have special approval. Member states are compiling
national lists of claims and will submit them to the European Commission. After consultation
with the European Food Safety Authority (EFSA), the final Community list of permitted claims
should be adopted by early 2010 (De Jong, 2007).

In Australia and New Zealand, the bi-national regulator – Food Standards Australia New Zealand
(FSANZ) - is currently developing a new standard which will permit scientifically substantiated
claims for foods that meet certain nutrient profiling criteria (FSANZ, 2008a). The proposed new
standard will encompass two types of claims - nutrition content claims and health claims – and
there will be two levels of health claims: general level health claims and high level health claims.
The level of a claim will determine how the claim is regulated, including the evidence required
for substantiation.

General level health claims refer to the presence of a nutrient or substance in a food and its effect
on normal health function. High-level health claims are those that make reference to a serious
disease or biomarker and these will need to be pre-approved by FSANZ. Five high-level claims
have already been accepted for inclusion in the new standard, including two related to calcium,
vitamin D and osteoporosis, and calcium and enhanced bone density. In the future,
manufacturers will be able to make applications for approval of other high level health claims,
which will need to be scientifically substantiated using a defined substantiation framework.

A view has been expressed that the ethical responsibility for marketing sound health messages
for dairy products rests with the industry. Although there are regulatory processes in place to
protect the consumer, these sometimes can be circumvented. Making a health claim requires a
certain level of proof for it to be accepted, and the food industry should strive to meet these
challenges. Consideration must also be given to potential negative effects, such as the
denigration of the product category, by the use of unsubstantiated health claims which may
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mislead the consumer (MacNeill, 2003). Consumers often express concern that health claims are
just another sales tool, and the use of poorly substantiated claims could increase the current
levels of consumer scepticism about all attempts to communicate the health benefits of food
(Health Canada, 2000; Food Standards Agency, 2004).

A cautionary note with respect to making less than fully-substantiated claims for foods lies in the
recent litigation brought by a group of overweight children against the McDonald's Corporation
that sought compensation for obesity-related health problems. While many derided this lawsuit
as representing the worst excesses of the tort liability system, others have drawn parallels to
tobacco litigation. Food-related litigation raises the question of where accountability for the
economic and public health consequences of food-related disorders properly rests (Mello et al,
2003).

It is anticipated that technological advances in the food industry, in conjunction with extensive
clinical trials and governmental control, will eventually guarantee the credibility of health claims
and ensure consumers’ confidence in functional foods (Arvanitoyannis and Van HouwelingenKoukaliaroglu, 2005).

Communication of Health Messages to Consumers

The new EU legislation on nutrition and health claims emphasises that the wording of claims
should be understandable and meaningful to the consumer and they will only be permitted if the
average consumer can be expected to understand the beneficial effects expressed in the claims
(Leathwood et al, 2007).

Recent trends in the USA and the EU indicate that regulators will require further research to test
how consumers are likely to interpret and use any health claim. In a recent study of television
food advertisements in the USA, 14.9% made a weight-related nutritional claim. The authors
concluded that practitioners and policy makers should be aware of the prevalence of food
advertisements and their potential impact on knowledge and behaviour and should consider
working more closely with food manufacturers to encourage the creation and promotion of
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weight-friendly foods. Furthermore, it was suggested that nutrition educators could help by
teaching consumers critical thinking skills that may relate to food advertisements (Henderson
and Kelly, 2005). Similar conclusions were reached in a study of food advertisements in a series
of women’s magazines (Hickman et al. 1993).

Consumer perceptions of nutrition- and health-related food claims attached to food products have
been investigated in a large-scale, cross-national, internet-based survey. Participants were
questioned in Germany (n = 1620), the UK (n = 1560), Italy (n = 1566) and the US (n = 1621).
Nutrition and health claims relating to 6 health benefits (increased concentration, decreased
overweight, fatigue, infection, stress and cardiovascular disease) and 5 claim types (marketing,
content, structure-function, disease risk reduction and product) were studied. Considerable
variations in consumer perception were found according to country of origin and benefit being
claimed, but not in relation to claim type (Trijp and Lans, 2007)
It has been reported that young consumers are not interested in the effects of eating habits on
health, whilst concern over consumption habits and health increases in older people. Young and
middle aged male consumers only read the energy value and nutritional information on the food
label, while female consumers read all the information on the labels of products which they
purchased. Increase in educational level has also been reported to increase the preference for
healthier foods (Isleten et al, 2007).
The use of health claims on the internet and the level of compliance of these claims with existing
regulations in Australia and New Zealand has been studied recently (Dragicevich et al, 2006).
This data showed that 14.5% of food product websites carried a health claim, and 40.7 and
37.0% of products previously identified as carrying claims on product labels or in magazines,
respectively, had internet claims. Many of the claims (19.7%) were high-level or therapeutic
claims not permitted by current food standards. The authors concluded that health claims were
not being made more frequently on websites compared with product labels, but there was a
greater prevalence of high-level and therapeutic claims made on the internet. In future, food
standards enforcement will need to give greater priority to monitoring the use of health claims on
the internet (Dragicevich et al, 2006). A similar study by the same group of magazine
advertisements has also found that many of the claims were high level claims (29%) or
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therapeutic claims (8%), which are not permitted by current food standards (Williams et al,
2007). In this study 17% of the advertisements with health claims were for dairy foods.
Food labels are an important tool to assist consumers in making healthy food choices. In addition
to mandatory nutritional labelling information, manufacturers have a variety of options on
food/supplement packages to communicate the nutrition/health benefits of their products
(Agarwal et al. 2006).

The FDA food labelling regulations aim to ensure that manufacturers aid consumers in making
dietary choices by eliminating ''hollow'' health claims. Of particular concern are health claims
made by one brand when the claim is inherent to the product category, but has not been featured
previously in advertisements or on packaging. There is concern that consumers will use
information provided by one brand about such an attribute to infer that the other brands in the
product category do not possess the attribute and thus be misled. Results from three experiments
show that this practice can mislead consumers and affect consumer inferences, use of the target
attribute, and choice in favour of the brands displaying the attribute. Furthermore, it was shown
that improved consumer education can be achieved without the deception associated with narrow
(brand-specific) health claims by using broader (category-defined) claims (Burke et al. 1997).

A study of consumers (Urala et al, 2003) has been carried out to evaluate whether productrelated health claims in foods are advantageous or disadvantageous. Claims were made for six
functional components and two control products. In general, all claims were perceived as neutral
or as advantageous. Increasing the strength of the claim did not automatically increase the
perceived benefit. Gender, trust in different information sources and the frequency of use of socalled functional foods affected the perceived benefit. Women perceived the claims to be more
beneficial than did men. Trustful respondents perceived the claims as more advantageous than
did sceptical respondents, and the users of functional foods perceived health claims to be more
advantageous than did non-users. In addition, personal motivation affected the perception of the
claims. With less familiar functional components, the strength of the claim increased the
perceived benefit, whereas with familiar components, claims mentioning the reduced risk or
prevention of a disease did not increase the perceived advantage.
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A further study by the same group (Urala and Lahteenmaki, 2004) quantified the attitudes behind
consumers' willingness to use these products. Functional food-related statements formed seven
factors describing consumers' attitudes towards functional foods. These factors were: perceived
reward from using functional foods, confidence in functional foods, necessity for functional
foods, functional foods as medicines, absence of nutritional risks in functional foods, functional
foods as part of a healthy diet and the health effects of functional foods versus their taste. These
attitude subscales differentiated between consumers in their reported willingness to use
functional foods. The best predictor for willingness to use functional foods was the perceived
reward.

One dilemma with health claims is that too much information can confuse consumers and too
little information can mislead them. A controlled study has been used to examine the
effectiveness of various front-sided health claims when used in combination with a full health
claim on the back of a package. The results indicated that combining short health claims on the
front of a package with full health claims on the back of the package leads consumers to more
fully process and believe the claim (Wansink, 2003).

A similar approach has been used in a recent study comparing claims about reduced risk of
osteoporosis made on milk or a calcium-fortified orange juice packaging. This study investigated
whether splitting a claim (a brief claim at the front of a package directing consumers to the full
health claim at the back), and/or endorsement of the claim (by a regulatory body), affected the
acceptance of the claim, by the consumer. Split health claims produced more positive responses
than not-split claims in several areas: they created a higher level of satisfaction with the
labelling, they produced a higher level of trust, and they communicated better the health risk of
the claim. Endorsement of the claim did not influence responses, possibly because of either the
small print of the approval statement or the low awareness of the regulatory body among
consumers, but belief in the claim was significantly higher on the milk product compared to the
juice (Singer et al. 2006).

Consumers' main scepticism regarding functional foods resides in the veracity of health claims
and in the often inadequate control of their claimed properties. It is very important that health
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claims on food products can be understood by the consumer. However, there is no clear
understanding of how consumers use health claims and their likely impact on consumer food
behaviour or health. More research is needed, but a review of previous studies allows some
common conclusions to be drawn. Health claims on foods are seen by consumers as useful, and
when a product features a health claim they view it as healthier and state they are more likely to
purchase it. Consumers are sceptical of health claims from food companies and strongly agree
that they should be endorsed by government. Consumers do not make clear distinctions between
nutrition content claims, structure-function claims and health claims. They generally do not like
long and complex, scientifically worded claims on foods; they prefer split claims - with a short
succinct statement of the claim on the front of pack and more detail provided elsewhere
(Williams, 2005a). There is also some evidence that the use of health claims improves the quality
of dietary choices and knowledge of diet-disease relationships (Williams, 2005b).

Dairy foods have long been promoted using health messages - dairy products have been
promoted by governmental authorities wanting to improve public health and by dairy industry
bodies promoting dairy foods. The health messages that have been used for the promotion of
dairy foods include nutrient content messages (“a good source of calcium”), low-fat messages
and health claims (“calcium reduces the risk of osteoporosis”). The changes in legislation
permitting the use of (some) health claims beyond structure –function claims (“calcium helps
promote bone health”) on food labels and in advertisements aimed at consumers will expand the
repertoire of messages available to communicate the benefits of dairy foods. However, health
claims will not replace nutrient content and low-fat messages, and all three types of health
messages are likely to be widely used to promote dairy foods in the future (Lawrence, 2005).

Nutrient profiling

Nutrient profiling of foods is defined as the science of categorizing foods based on their nutrient
composition. For regulatory agencies, nutrient profiles can be the basis for disallowing nutrition
or health claims and for regulating advertising to children. The EU and Australia/New Zealand
have adopted nutrient profiling as the basis for regulating nutrition and health claims; whereas
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the US approach has emphasized positive nutrients and the European approach has focused on
the foods' content of fats, trans-fats, sugars and sodium. The Australian approach proposes a
mixed scoring system of disqualifying nutrients (e.g. high salt, sugar, fat) balanced with positive
scores for protein, fibre, fruit and vegetable content (FSANZ 2008b).
Several nutrient profiling approaches are being used in different countries. It has been reported
that 23 nutrient profiling systems have been developed (Garsetti et al, 2007). One approach uses
thresholds where an upper limit is set for negatively perceived nutrients. As positive/healthy
nutrients are not taken into account, this system does not reflect the whole nutrient composition
of a food, and as such would not recognise the importance of dairy foods in helping to meet
nutritional requirements. Another approach is the use of scoring systems that allow the inclusion
of both positive and negative nutrients, and these provide a more balanced view of the nutrient
composition. However, a potential problem with this system is that if energy, total fat, saturated
fat and sugars are all included in such a model, this can lead to multiple scoring of some
nutrients such as fat. A further approach is based on nutrient density. Nutrient density is the ratio
of the amount of a nutrient in a food to the energy provided by that food. This approach
differentiates between energy dense, but nutritionally poor foods, and foods that are both energy
dense and nutrient dense. Dairy foods are naturally nutrient dense, and their contribution to
nutrient intake is well represented by this approach (IDF, 2007).
Nutrient profiling or scoring criteria can pose some challenges for dairy product manufacturers.
Dairy products such as cheese and butter are naturally high in nutrients that would result in their
disqualification from being able to make a health claim. For example, using the values for
energy, saturated fat, sugar and sodium initially proposed by FSANZ, most cheeses could not
carry a health claims in Australia or New Zealand because of their inherently high energy,
saturated fat and sodium content. This is despite the fact that the National Health and Medical
Research Council’s (NHMRC) Dietary Guidelines for Australian Adults recommend that adult
diets include milk, yoghurt and cheese (Lederman, 2007). Subsequent modifications to the
profiling system have included a separate set of criteria for cheeses with a calcium content of
more than 320mg/100g (FSANZ 2008b).
The development of competing nutrient profile systems by researchers, regulatory agencies, and
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the food industry in the EU, the US and elsewhere, has been marked by different priorities,
pressures and concerns. However, the development of nutrient profiles needs to follow specific
science-driven rules. These include the selection of reference nutrients and reference amounts,
the creation of an appropriate algorithm for calculating nutrient quality scores, and the validation
of the chosen scheme against objective measures of a healthy diet (Drewnowski, 2007).
The application of nutrient profiling also aims to avoid a situation where nutrition or health
claims mask the overall nutritional status of a food, which could mislead consumers when they
are attempting to make decisions in the context of a balanced diet (Reuterswärd, 2007)

Regulation of functional foods and food supplements in Japan

A policy of "Foods for Specified Health Uses" (FOSHU), by which health claims on some
selected functional foods are legally permitted was established in 1993 by the Japanese Ministry
of Health and Welfare. Since 1984, when the concept of "functional food" was first proposed
there, the science of regulating and labelling functional foods in Japan has been progressing
along a unique path of development. Their unique approach is seen in the development of
functional foods by minimizing undesirable as well as maximizing desirable food factors, for
example, hypoallergenic foods, developed from food materials by removing allergens (Arai,
2000).

The concept of 'functional foods' is well understood in Japan as a result of research initiated on
the health benefits of foods in 1984. The Ministry of Education organized a national research and
development project to evaluate the functionalities of various foods. Researchers from diverse
scientific fields defined new functions of food, successfully incorporating previously recognized
functions of nutrition, sensory/satisfaction and physiological effects of ingredients in foods.

Some food manufacturers and distributors unfortunately capitalized on such food functionalities
to promote 'health foods' by violating the laws with claims for drug-like effects. In 1991, the
Ministry of Health and Welfare’s successor, the Ministry of Health, Labor and Welfare
(MHLW), introduced a 'foods for specified health uses' (FOSHU) system, to control such
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exaggerated and misleading claims. The other reason for such enforcement was an increase in
the population of elderly people and lifestyle-related diseases, including obesity, diabetes
mellitus, high blood pressure, cerebro- and cardiovascular diseases and cancer.

In 2001, a new regulatory system, 'foods with health claims' (FHC) with a 'foods with nutrient
function claims' (FNFC) system and newly established FOSHU was introduced. The MHLW
further changed the FOSHU, FNFC and other systems in 2005. Such changes included new subsystems of FOSHU such as (1) Regular/Specific FOSHU (including disease risk reduction
claims), (2) standardized FOSHU and (3) qualified FOSHU (Ohama et al, 2006).

Regular/Specific FOSHU (including reduction of disease risk) refers to foods intended for
consumer products, where safety and efficacy regarding health claims have been proven by a
series of safety/stability tests and clinical trials, and have been approved by the MHLW to make
health claims for the specific product.

Standardized FOSHU was introduced in February 2005 and represents foods that contain certain
effective ingredients that are proven to meet the standards and specifications for a specific health
claim, ingredient and/or quality standard. Food that has an accumulation of scientific evidence
(more than 100 cases of past approvals as FOSHU) can be approved as a Standardized FOSHU
upon sole review of MHLW, without needing an individual review by the examination council.

Qualified FOSHU, also introduced in February 2005, refers to foods with certain effectiveness,
but whose scientific data are less conclusive than those required for the existing FOSHU
standard.

There are three requirements that are essential for the approval of a FOSHU application. These
are (a) scientific evidence of the effectiveness of the product, proven by clinical studies, (b)
additional safety studies or other evidence to prove that there are no side-effects following oral
intake and (c) an exact determination of the specific effective component (Anon, 2007).
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The regulatory range of FOSHU has been broadened to accept capsules and tablets, in addition to
conventional foods. The MHLW regulatory system, ‘Foods with Health Claims’ (FHC), consists
of the existing FOSHU system and the newly established ‘Foods with Nutrient Function Claims’
(FNFC).

FNFC refers to foods that are intended for consumption as supplements and are defined as “food
products with supplemental nutritional components that are likely to be deficient in the elderly
and other persons who deviate from normal eating habits due to an irregular lifestyle.” Vitamins
(A, B1, B2, B6, B12, C, D, E, Niacin, Folic Acid, Biotin and Pantothenic Acid) plus 5 minerals
(Calcium, Iron, Zinc, Copper and Magnesium) have been placed in this group (Anon, 2007).
Examples of claims regarding these substances include: 'Calcium is a nutrient which is necessary
to form bones and teeth'; 'Vitamin D is a nutrient which promotes calcium absorption in the gut
intestine and aids in the formation of bones'. The upper and lower levels of the daily
consumption of these nutrients are also determined.

The claims of the Japanese FNFC are equivalent to the nutrient function claims standardized by
the Codex Alimentarius. The enhanced function claim and the disease risk-reduction claims were
proposed by both the Codex Alimentarius and an Economic Union project in 1999. The structure
function claim, which is similar to the enhanced function claim, was enacted by the Dietary
Supplement Health and Education Act in the USA in 1994. Most of the statements of the
Japanese FOSHU system are close to the structure/function claims in the USA or the enhanced
function claims of the Codex Alimentarius (Shimizu, 2003).

Food for Specified Uses (FOSU) or Food for Special Dietary Uses (FOSDU) is one of the
categories of Food with Health Claims that is not regulated by the Food Hygiene Law, but rather
by the Health Promotion Law. FOSU refers to foods that have been deemed appropriate for
specified dietary purposes, such as infant nutrition, pregnant and lactating women, the
maintenance of general health and recovery from illness. Individual consumer products are
examined on a case-by-case basis and must be approved before being permitted to display that
the food is appropriate for special dietary uses (Anon, 2007).
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Codex Alimentarius

The Codex Alimentarius (Latin for “food law” or “food code”) is a collection of internationally
recognized standards, codes of practice, guidelines and other recommendations relating to foods,
food production and food safety under the aegis of consumer protection. Officially, it is
maintained by the Codex Alimentarius Commission, a body established jointly by the Food and
Agriculture Organization of the United Nations (FAO), and the World Health Organization
(WHO) in 1963 to protect the health of consumers and ensure fair practices in international food
trade. Codex standards are used by many countries as benchmarks when developing local food
regulations.
The Codex Alimentarius position is that health claims should be permitted provided that all of
the following conditions are met:
•

Health claims must be based on current relevant scientific substantiation and the level of
proof must be sufficient to substantiate the type of effect claimed and the relationship to
health as recognised by generally accepted scientific review of the data and the scientific
substantiation should be reviewed as new knowledge becomes available. The health claim
must consist of two parts:

(i)

Information on the physiological role of the nutrient or on an accepted diet-health
relationship; followed by

(ii)

Information on the composition of the product relevant to the physiological role
of the nutrient or the accepted diet-health relationship unless the relationship is
based on a whole food or foods whereby the research does not link to specific
constituents of the food.

•

Any health claim must be accepted by, or be acceptable to, the competent authorities of the
country where the product is sold.
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•

The claimed benefit should arise from the consumption of a reasonable quantity of the food
or food constituent in the context of a healthy diet.

•

If the claimed benefit is attributed to a constituent in the food, for which a Nutrient
Reference value is established, the food in question should be:

(i)

A source of, or high in, the constituent in the case where increased consumption is
recommended, or,

(ii)

Low in, reduced in, or free of the constituent in the case where reduced
consumption is recommended. Where applicable, the conditions for nutrient
content claims and comparative claims will be used to determine the levels for
“high”, “low”, “reduced”, and “free”.

•

Health claims should have a clear regulatory framework for qualifying and/or disqualifying
conditions for eligibility to use the specific claim, including the ability of competent national
authorities to prohibit claims made for foods that contain nutrients or constituents in
amounts that increase the risk of disease or an adverse health-related condition. The health
claim should not be made if it encourages or condones excessive consumption of any food
or disparages good dietary practice.

•

If the claimed effect is attributed to a constituent of the food, there must be a validated
method to quantify the food constituent that forms the basis of the claim.

•

The following information should appear on the label or labelling of the food bearing health
claims:

- A statement of the quantity of any nutrient or other constituent of the food that is the
subject of the claim.
- The target group, if appropriate.
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- How to use the food to obtain the claimed benefit and other lifestyle factors or other
dietary sources, where appropriate.
- If appropriate, advice to vulnerable groups on how to use the food and to groups, if any,
who need to avoid the food.
- Maximum safe intake of the food or constituent where necessary.
- How the food or food constituent fits within the context of the total diet.
- A statement on the importance of maintaining a healthy diet (CAC, 2004).

Process for the Assessment of Scientific Support for Claims on Foods (PASSCLAIM)

The European Commission concerted action PASSCLAIM aimed to produce a generic tool for
assessing the scientific support for health-related claims for foods and food components (Prentice
et al, 2003) as a result of the attention being paid to claims for foods, especially those related to
the newly discovered effects of dietary components on body functions. The PASSCLAIM
project, which ran from 2001 to 2005, built upon the principles defined in publications arising
out of the EU DG XII Functional Food Science in Europe (FUFOSE) project.

The main thrust of the Consensus Document on Scientific Concepts of Functional Foods in
Europe, produced as the final deliverable from the FUFOSE Concerted Action, was to suggest
the outline of a scheme to link claims for functional foods to solid scientific evidence. FUFOSE
suggested that claims for "enhanced function" and for "reduced risk of disease" are only
justifiable when they are based on appropriate, validated markers of exposure, enhanced function
or reduction of disease risk.
The objectives of PASSCLAIM were:
•

To produce a generic tool with principles for assessing the scientific support for healthrelated claims for foods and food components which are eatable or drinkable.

•

To critically evaluate the existing schemes which assess the scientific substantiation of
claims, and

•

To select common criteria for how markers should be identified, validated and used in
well-designed studies to explore the links between diet and health.
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The criteria for the scientific substantiation of health claims on foods defined by the
PASSCLAIM project were as follows:

•

The food or food component to which the claimed effect is attributed should be
characterised.

•

Substantiation of a claim should be based on human data, primarily from intervention
studies.

•

When the true endpoint of a claimed benefit cannot be measured directly, studies should
use markers.

•

Markers should be biologically valid (i.e. they should have a known relationship to the
final outcome), and be methodologically valid with respect to their analytical
characteristics.

•

Within a study, the target variable should change in a statistically significant way.

•

A claim should be scientifically substantiated by taking into account the totality of the
available data and by weighing up of the evidence.

Potential health claims can be based not only on modifications of target body functions (for
obesity: body fat deposition), but also on other relevant associated functions (for obesity: energy
intake, energy expenditure and fat deposition) and should be evaluated using valid
methodologies. According to the PASSCLAIM consensus document, the substantiation of health
claims should take into account the totality of the available data; however, it should be based on
human data, primarily from intervention studies with an appropriate design and a relevant endpoint (Riccardi and Giacco, 2005).

19

Regardless of the different approaches to the use of health claims on foods taken around the
world, their common theme is that any health claim will require scientific validation and
substantiation. There is also broad consensus that any regulatory framework should protect the
consumer, promote fair trade and encourage innovation in the food industry. There is a need to
have uniform understanding, terminology and description of types of nutrition and health claims.
The two broad categories defined within PASSCLAIM were: (i) Nutrition Claims, i.e. what the
product contains, and (ii) Health Claims, i.e. relating to health, well-being and/or performance,
including well-established nutrient function claims, enhanced function claims and disease risk
reduction claims (Richardson et al. 2003).

USA Food and Drug Administration (FDA)

The USA Food and Drug Administration's regulatory authority over health claims was clarified
in 1990 legislation known as the Nutrition Labelling and Education Act (NLEA). This law
established mandatory nutrition labelling for most foods and placed restrictions on food label
claims characterizing the levels or health benefits of nutrients in foods. NLEA set a high
threshold for the scientific standard under which the FDA may authorize health claims; this
standard is known as the significant scientific agreement (SSA) standard. An alternative to the
FDA review of health claims was established in subsequent legislation (the FDA Modernization
Act, 1997) which provided a USA government scientific body, other than the FDA, to establish
that there is SSA for a substance/disease relationship.

Courts have since extended the scope of health claims to include qualified health claims (QHC)
that are health claims not substantiated on evidence that meets the level of SSA standard, but
include a qualifying statement intended to convey to the consumer the level of evidence for the
claim. FDA has responded by developing an evidence-based ranking system for scientific data to
determine the level of evidence substantiating a health claim, and established a system with four
different levels of substantiation (Rowlands and Hoadley, 2006). However, it appears consumers
are confused by the system of qualified health claims. They find it difficult to understand the
meaning of the different types of qualified claims and may even interpret the qualification levels
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to refer to the overall safety of the product rather than an evaluation of the strength of the
scientific substantiation (IFIC, 2005).

Generally Recognized As Safe (GRAS) Status

The FDA in the USA had set the bar too high for health claims and was forced by the courts to
implement a more reasonable standard, but the response, Qualified Health Claims, has failed to
gain the confidence of the public because of the confusing wording of the claims demanded by
FDA. The Dietary Supplement Health and Education Act (DSHEA) was the product of a
compromise with a lower threshold for demonstration of safety (reasonable expectation of no
harm) that would be met by consumer self-policing and assumption of some risk. FDA has
thwarted this effort by raising the bar for New Dietary Ingredient Notifications (NDIN) to what
appears to be the higher threshold for the safety of food ingredients (reasonable certainty of no
harm). The FDA apparently sees these two safety thresholds as a distinction without a difference.
As a result, increasing numbers of dietary supplement manufacturers, unwilling to gamble the
future of their products to a system that provides little hope for the FDA's response of "no
objection", have committed the additional resources necessary to obtain Generally Recognized
As Safe (GRAS) status for their supplements.

The pressure on FDA and Congress for change is again building with increased dissatisfaction
among consumers as the result of confusing labels. A second force for change will be a need to
uncouple the FDA mandated substance-disease relationship and return to the substance-claim
relationship to allow for progress in nutrigenomics and metabolomics, which will result in an
increasing number of substance-biomarker claims (Burdock et al. 2006).

Conclusion

Scientific discoveries and increasing interest in the potential health benefits of foods and food
components have resulted in a range of content-, structure function- and health-claims. The
clinical and epidemiological evidence on the way each particular dietary component fosters
growth and development, healthy functioning and disease prevention is expanding. However,
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defining a single ideal diet is complicated by the many factors that may influence biological
processes.

The diversity of findings in the literature may reflect the multi-factorial nature of these
processes. New and emerging genomic and proteonomic approaches and technologies offer the
prospect of identifying molecular targets for dietary components, thereby possibly determining
the mechanisms by which specific individual dietary constituents modify the genetic and
epigenetic events that influence the quality of life. Expanded knowledge on unique cellular
characteristics with molecular targets for nutrients thus may be able to be used to develop
strategies to optimize nutrition and minimize disease risk (Milner, 2002).

This increasing emphasis on food and its component ingredients to reduce disease risk and
promote health requires the development of accurate biomarkers for predicting outcomes of
food-based interventions. Improved knowledge of human genomics and the ability to use
microarray technology to screen for biomarkers at the gene level may provide the opportunity for
individuals to be diagnosed for and informed of their own particular disease risk profile.

It remains to be seen whether or not these technologies will provide sufficient understanding of
food-gene interactions to permit more certain health claims rather than better therapeutic
treatments (Roberts, 2002). The application of such personalised nutrition, from the earliest stage
of life, including in utero, will present significant challenges for the substantiation of health
claims in the post-genome era (McGinty and Man, 2007).

Manufacturers will face increasing demands to provide high quality scientific data before
approvals for health claims are granted. They will also need to consider the economics of the
time and expense of scientific substantiation / clinical data to support claims, even if these result
in higher consumer confidence in the resulting claims.

Consumer research shows that dairy foods like yoghurt are viewed as desirable and credible
carriers of functional ingredients, particularly over indulgent foods such as chocolate (Kleef et al,
2005). Dairy foods are also less likely to face the disqualifying criteria for health claims of
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addition of a healthy ingredient into a less-than-healthy food vehicle, or the high threshold values
for less than healthy nutrients (e.g. high sugar content) now being included in codes by some
regulatory bodies.

Dairy foods and ingredients have a natural advantage over new/novel foods, from a regulatory
viewpoint, because they are generally considered as “traditional” foods, that is, there is a long
history of human consumption. However, the regulatory landscape on adding bioactive
ingredients, whether from dairy streams or from non-dairy sources, into dairy foods is rapidly
evolving, and the dairy industry will need to be aware of potential regulatory challenges, within
the countries they wish to market their products.
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